1
|
Chellappan DK, Chellian J, Rahmah NSN, Gan WJ, Banerjee P, Sanyal S, Banerjee P, Ghosh N, Guith T, Das A, Gupta G, Singh SK, Dua K, Kunnath AP, Norhashim NA, Ong KH, Palaniveloo K. Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources. Diabetes Metab Syndr Obes 2023; 16:2187-2223. [PMID: 37521747 PMCID: PMC10386840 DOI: 10.2147/dmso.s390741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2023] [Accepted: 07/12/2023] [Indexed: 08/01/2023] Open
Abstract
Diabetes mellitus (DM) is a chronic metabolic disorder recognized as a major health problem globally. A defective insulin activity contributes to the prevalence and expansion of DM. Treatment of DM is often hampered by limited options of conventional therapies and adverse effects associated with existing procedures. This has led to a spike in the exploration for potential therapeutic agents from various natural resources for clinical applications. The marine environment is a huge store of unexplored diversity of chemicals produced by a multitude of organisms. To date, marine microorganisms, microalgae, macroalgae, corals, sponges, and fishes have been evaluated for their anti-diabetic properties. The structural diversity of bioactive metabolites discovered has shown promising hypoglycaemic potential through in vitro and in vivo screenings via various mechanisms of action, such as PTP1B, α-glucosidase, α-amylase, β-glucosidase, and aldose reductase inhibition as well as PPAR alpha/gamma dual agonists activities. On the other hand, hypoglycaemic effect is also shown to be exerted through the balance of antioxidants and free radicals. This review highlights marine-derived chemicals with hypoglycaemic effects and their respective mechanisms of action in the management of DM in humans.
Collapse
Affiliation(s)
- Dinesh Kumar Chellappan
- Department of Life Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia
| | - Jestin Chellian
- Department of Life Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia
| | | | - Wee Jin Gan
- School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia
| | - Priyanka Banerjee
- Department of Pharmaceutical Technology, School of Medical Sciences, Adamas University, Kolkata, West Bengal, India
| | - Saptarshi Sanyal
- Department of Pharmaceutical Technology, School of Medical Sciences, Adamas University, Kolkata, West Bengal, India
| | | | - Nandini Ghosh
- Indiana University School of Medicine, Indianapolis, IN, USA
| | - Tanner Guith
- Indiana University School of Medicine, Indianapolis, IN, USA
| | - Amitava Das
- Indiana University School of Medicine, Indianapolis, IN, USA
| | - Gaurav Gupta
- School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, 302017, India
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, 248007, India
- Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Science, Chennai, India
| | - Sachin Kumar Singh
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India
- Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia
| | - Kamal Dua
- Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia
- Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia
| | - Anil Philip Kunnath
- Division of Applied Biomedical Science and Biotechnology, School of Health Sciences, International Medical University, Kuala Lumpur, 57000, Malaysia
| | - Nur Azeyanti Norhashim
- Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, Core Technology Facility, The University of Manchester, Manchester, M13 9NT, UK
- Institute of Ocean and Earth Sciences, University of Malaya, Kuala Lumpur, 50603, Malaysia
| | - Kuan Hung Ong
- Institute of Ocean and Earth Sciences, University of Malaya, Kuala Lumpur, 50603, Malaysia
| | - Kishneth Palaniveloo
- Institute of Ocean and Earth Sciences, University of Malaya, Kuala Lumpur, 50603, Malaysia
| |
Collapse
|
2
|
Eguchi N, Toribio AJ, Alexander M, Xu I, Whaley DL, Hernandez LF, Dafoe D, Ichii H. Dysregulation of β-Cell Proliferation in Diabetes: Possibilities of Combination Therapy in the Development of a Comprehensive Treatment. Biomedicines 2022; 10:biomedicines10020472. [PMID: 35203680 PMCID: PMC8962301 DOI: 10.3390/biomedicines10020472] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 02/12/2022] [Accepted: 02/15/2022] [Indexed: 02/01/2023] Open
Abstract
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia as a result of insufficient insulin levels and/or impaired function as a result of autoimmune destruction or insulin resistance. While Type 1 DM (T1DM) and Type 2 DM (T2DM) occur through different pathological processes, both result in β-cell destruction and/or dysfunction, which ultimately lead to insufficient β-cell mass to maintain normoglycemia. Therefore, therapeutic agents capable of inducing β-cell proliferation is crucial in treating and reversing diabetes; unfortunately, adult human β-cell proliferation has been shown to be very limited (~0.2% of β-cells/24 h) and poorly responsive to many mitogens. Furthermore, diabetogenic insults result in damage to β cells, making it ever more difficult to induce proliferation. In this review, we discuss β-cell mass/proliferation pathways dysregulated in diabetes and current therapeutic agents studied to induce β-cell proliferation. Furthermore, we discuss possible combination therapies of proliferation agents with immunosuppressants and antioxidative therapy to improve overall long-term outcomes of diabetes.
Collapse
|
3
|
Corraliza-Gómez M, Gallardo AB, Díaz-Marrero AR, de la Rosa JM, D’Croz L, Darias J, Arranz E, Cózar-Castellano I, Ganfornina MD, Cueto M. Modulation of Glial Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of Obesity and Insulin Resistance. Mar Drugs 2020; 18:E378. [PMID: 32708004 PMCID: PMC7459604 DOI: 10.3390/md18080378] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 07/09/2020] [Accepted: 07/20/2020] [Indexed: 02/06/2023] Open
Abstract
Neurodegenerative diseases are age-related disorders caused by progressive neuronal death in different regions of the nervous system. Neuroinflammation, modulated by glial cells, is a crucial event during the neurodegenerative process; consequently, there is an urgency to find new therapeutic products with anti-glioinflammatory properties. Five new furanocembranolides (1-5), along with leptolide, were isolated from two different extracts of Leptogorgia sp., and compound 6 was obtained from chemical transformation of leptolide. Their structures were determined based on spectroscopic evidence. These seven furanocembranolides were screened in vitro by measuring their ability to modulate interleukin-1β (IL-1β) production by microglial BV2 cells after LPS (lipopolysaccharide) stimulation. Leptolide and compounds 3, 4 and 6 exhibited clear anti-inflammatory effects on microglial cells, while compound 2 presented a pro-inflammatory outcome. The in vitro results prompted us to assess anti-glioinflammatory effects of leptolide in vivo in a high-fat diet-induced obese mouse model. Interestingly, leptolide treatment ameliorated both microgliosis and astrogliosis in this animal model. Taken together, our results reveal a promising direct biological effect of furanocembranolides on microglial cells as bioactive anti-inflammatory molecules. Among them, leptolide provides us a feasible therapeutic approach to treat neuroinflammation concomitant with metabolic impairment.
Collapse
Affiliation(s)
- Miriam Corraliza-Gómez
- Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, 47003 Valladolid, Spain; (M.C.-G.); (E.A.); (I.C.-C.)
| | - Amalia B. Gallardo
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
- Departamento de Ciencias y Recursos Naturales, Facultad de Ciencias, Universidad de Magallanes, Avenida Bulnes 01855, Punta Arenas, Chile
| | - Ana R. Díaz-Marrero
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| | - José M. de la Rosa
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| | - Luis D’Croz
- Departamento de Biología Marina y Limnología, Universidad de Panamá, Panama 3366, Panama;
- Smithsonian Tropical Research Institute, STRI, Box 0843-03092 Balboa, Panama
| | - José Darias
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| | - Eduardo Arranz
- Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, 47003 Valladolid, Spain; (M.C.-G.); (E.A.); (I.C.-C.)
| | - Irene Cózar-Castellano
- Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, 47003 Valladolid, Spain; (M.C.-G.); (E.A.); (I.C.-C.)
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain
| | - María D. Ganfornina
- Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, 47003 Valladolid, Spain; (M.C.-G.); (E.A.); (I.C.-C.)
| | - Mercedes Cueto
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| |
Collapse
|
4
|
Porras G, Díaz-Marrero A, de la Rosa J, D'Croz L, de Pablo N, Perdomo G, Cózar-Castellano I, Darias J, Cueto M. Cembranoids from Eunicea sp. enhance insulin-producing cells proliferation. Tetrahedron 2018. [DOI: 10.1016/j.tet.2018.03.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
5
|
Gallardo AB, Díaz-Marrero AR, de la Rosa JM, D’Croz L, Perdomo G, Cózar-Castellano I, Darias J, Cueto M. Chloro-Furanocembranolides from Leptogorgia sp. Improve Pancreatic Beta-Cell Proliferation. Mar Drugs 2018; 16:md16020049. [PMID: 29393907 PMCID: PMC5852477 DOI: 10.3390/md16020049] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Revised: 01/19/2018] [Accepted: 01/29/2018] [Indexed: 12/14/2022] Open
Abstract
Two new chloro-furanocembranolides (1, 2) and two new 1,4-diketo cembranolides (3, 4) were isolated from the crude extract of Leptogorgia sp. together with a new seco-furanocembranolide (5) and the known Z-deoxypukalide (6), rubifolide (7), scabrolide D (8) and epoxylophodione (9). Their structures were determined based on spectroscopic evidence. Four compounds: 1, 2, 7 and 8 were found to activate the proliferation of pancreatic insulin-producing (beta) cells.
Collapse
Affiliation(s)
- Amalia B. Gallardo
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
- Departamento de Química, Facultad de Ciencias, Universidad de Magallanes, Avenida Bulnes 01855, Punta Arenas 6200000, Chile
| | - Ana R. Díaz-Marrero
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| | - José M. de la Rosa
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| | - Luis D’Croz
- Departamento de Biología Marina y Limnología, Universidad de Panamá, Panama City P.O. Box 3366, Panama;
- Smithsonian Tropical Research Institute, STRI, Balboa P.O. Box 0843-03092, Panama
| | - Germán Perdomo
- Facultad de Ciencias de la Salud, Universidad de Burgos, 09001 Burgos, Spain;
| | - Irene Cózar-Castellano
- Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47005 Valladolid, Spain;
| | - José Darias
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
| | - Mercedes Cueto
- Instituto de Productos Naturales y Agrobiología (IPNA-CSIC), Avenida Astrofísico F. Sánchez, 3, 38206 La Laguna, Tenerife, Spain; (A.B.G.); (A.R.D.-M.); (J.M.d.l.R.); (J.D.)
- Correspondence: ; Tel.: +34-922-250-144
| |
Collapse
|
6
|
Villa-Pérez P, Cueto M, Díaz-Marrero AR, Lobatón CD, Moreno A, Perdomo G, Cózar-Castellano I. Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice. Mar Drugs 2017; 15:md15090289. [PMID: 28914811 PMCID: PMC5618428 DOI: 10.3390/md15090289] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2017] [Revised: 08/22/2017] [Accepted: 09/13/2017] [Indexed: 12/31/2022] Open
Abstract
Type 2 diabetes (T2DM) is a complex disease linked to pancreatic beta-cell failure and insulin resistance. Current antidiabetic treatment regimens for T2DM include insulin sensitizers and insulin secretagogues. We have previously demonstrated that leptolide, a member of the furanocembranolides family, promotes pancreatic beta-cell proliferation in mice. Considering the beneficial effects of leptolide in diabetic mice, in this study, we aimed to address the capability of leptolide to improve insulin resistance associated with the pathology of obesity. To this end, we tested the hypothesis that leptolide should protect against fatty acid-induced insulin resistance in hepatocytes. In a time-dependent manner, leptolide (0.1 µM) augmented insulin-stimulated phosphorylation of protein kinase B (PKB) by two-fold above vehicle-treated HepG2 cells. In addition, leptolide (0.1 µM) counteracted palmitate-induced insulin resistance by augmenting by four-fold insulin-stimulated phosphorylation of PKB in HepG2 cells. In vivo, acute intraperitoneal administration of leptolide (0.1 mg/kg and 1 mg/kg) improved glucose tolerance and insulin sensitivity in lean mice. Likewise, prolonged leptolide treatment (0.1 mg/kg) in diet-induced obese mice improved insulin sensitivity. These effects were paralleled with an ~50% increased of insulin-stimulated phosphorylation of PKB in liver and skeletal muscle and reduced circulating pro-inflammatory cytokines in obese mice. We concluded that leptolide significantly improves insulin sensitivity in vitro and in obese mice, suggesting that leptolide may be another potential treatment for T2DM.
Collapse
Affiliation(s)
- Pablo Villa-Pérez
- Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, Valladolid 47005, Spain.
| | - Mercedes Cueto
- Instituto de Productos Naturales y Agrobiología (CSIC), La Laguna 38206, Spain.
| | - Ana R Díaz-Marrero
- Instituto Universitario de Bioorgánica "A. González", University of La Laguna, La Laguna 38206, Spain.
| | - Carmen D Lobatón
- Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, Valladolid 47005, Spain.
| | - Alfredo Moreno
- Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, Valladolid 47005, Spain.
| | - Germán Perdomo
- School of Nursery, University of Burgos, Burgos 09001, Spain.
| | - Irene Cózar-Castellano
- Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, Valladolid 47005, Spain.
| |
Collapse
|
7
|
López-Acosta JF, Villa-Pérez P, Fernández-Díaz CM, Román DDL, Díaz-Marrero AR, Cueto M, Perdomo G, Cózar-Castellano I. Protective effects of epoxypukalide on pancreatic β-cells and glucose metabolism in STZ-induced diabetic mice. Islets 2015; 7:e1078053. [PMID: 26406478 PMCID: PMC4878260 DOI: 10.1080/19382014.2015.1078053] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Diabetes is a consequence of a decrease on functional β-cell mass. We have recently demonstrated that epoxypukalide (Epoxy) is a natural compound with beneficial effects on primary cultures of rat islets. In this study, we extend our previous investigations to test the hypothesis that Epoxy protects β-cells and improves glucose metabolism in STZ-induced diabetic mice. We used 3-months old male mice that were treated with Epoxy at 200 μg/kg body weight. Glucose intolerance was induced by multiple intraperitoneal low-doses of streptozotocin (STZ) on 5 consecutive days. Glucose homeostasis was evaluated measuring plasma insulin levels and glucose tolerance. Histomorphometry was used to quantify the number of pancreatic β-cells per islet. β-cell proliferation was assessed by BrdU incorporation, and apoptosis by TUNEL staining. Epoxy treatment significantly improved glucose tolerance and plasma insulin levels. These metabolic changes were associated with increased β-cell numbers, as a result of a two-fold increase in β-cell proliferation and a 50% decrease in β-cell death. Our results demonstrate that Epoxy improves whole-body glucose homeostasis by preventing pancreatic β-cell death due to STZ-induced toxicity in STZ-treated mice.
Collapse
Affiliation(s)
- Jose F López-Acosta
- Instituto de Genética y Biología Molecular (University of Valladolid-CSIC); Valladolid, Spain
- These authors contributed equally to this work
| | - Pablo Villa-Pérez
- Instituto de Genética y Biología Molecular (University of Valladolid-CSIC); Valladolid, Spain
- These authors contributed equally to this work
| | | | - Daniel de Luis Román
- Svo Endocrinología y Nutrición HCUVA; Centro de Investigación de Endocrinología y Nutrición (University of Valladolid); Valladolid, Spain
| | - Ana R Díaz-Marrero
- Departamento de Química Orgánica; Instituto Universitario de Bioorgánica “Antonio González” -CIBICAN; University of La Laguna; San Cristóbal de La Laguna, Spain
| | - Mercedes Cueto
- Instituto de Productos Naturales y Agrobiología (CSIC); La Laguna, Tenerife, Spain
| | - Germán Perdomo
- Facultad de Ciencias Ambientales y Bioquimica; University of Castilla-La Mancha; Toledo, Spain
| | - Irene Cózar-Castellano
- Instituto de Genética y Biología Molecular (University of Valladolid-CSIC); Valladolid, Spain
- Correspondence to: Irene Cózar-Castellano;
| |
Collapse
|
8
|
Li Q, Lai ZC. Recent progress in studies of factors that elicit pancreatic β-cell expansion. Protein Cell 2014; 6:81-7. [PMID: 25492376 PMCID: PMC4312764 DOI: 10.1007/s13238-014-0123-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2014] [Accepted: 11/13/2014] [Indexed: 12/26/2022] Open
Abstract
The loss of or decreased functional pancreatic β-cell is a major cause of type 1 and type 2 diabetes. Previous studies have shown that adult β-cells can maintain their ability for a low level of turnover through replication and neogenesis. Thus, a strategy to prevent and treat diabetes would be to enhance the ability of β-cells to increase the mass of functional β-cells. Consequently, much effort has been devoted to identify factors that can effectively induce β-cell expansion. This review focuses on recent reports on small molecules and protein factors that have been shown to promote β-cell expansion.
Collapse
Affiliation(s)
- Qiu Li
- Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021 China
| | - Zhi-Chun Lai
- Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021 China
- Department of Biology, The Pennsylvania State University, University Park, PA 16802 USA
- Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802 USA
| |
Collapse
|
9
|
Kitagishi Y, Nakanishi A, Minami A, Asai Y, Yasui M, Iwaizako A, Suzuki M, Ono Y, Ogura Y, Matsuda S. Certain Diet and Lifestyle May Contribute to Islet β-cells Protection in Type-2 Diabetes via the Modulation of Cellular PI3K/AKT Pathway. Open Biochem J 2014; 8:74-82. [PMID: 25400709 PMCID: PMC4231374 DOI: 10.2174/1874091x01408010074] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Revised: 08/13/2014] [Accepted: 08/18/2014] [Indexed: 12/18/2022] Open
Abstract
PI3K/AKT pathway has been shown to play a pivotal role on islet β-cell protection, enhancing β-cell survival by stimulating cell proliferation and inhibiting cell apoptosis. Accordingly, this pathway appears to be crucial in type-2 diabetes. Understanding the regulations of this pathway may provide a better efficacy of new therapeutic approaches. In this review, we summarize advances on the involvement of the PI3K/AKT pathway in hypothetical intra-cellular signaling of islet β-cells. As recent findings may show the nutritional regulation of the survival pathway in the islet β-cells through activation of the PI3K/AKT pathway, we also review studies on the features of several diets, correlated lifestyle, and its signaling pathway involved in type-2 diabetes. The molecular mechanisms contributing to the disease are the subject of considerable investigation, as a better understanding of the pathogenesis will lead to novel therapies against a condition of the disease.
Collapse
Affiliation(s)
- Yasuko Kitagishi
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Atsuko Nakanishi
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Akari Minami
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Yurina Asai
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Mai Yasui
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Akiko Iwaizako
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Miho Suzuki
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Yuna Ono
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Yasunori Ogura
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| | - Satoru Matsuda
- Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan
| |
Collapse
|
10
|
Hu HY, Gehrig S, Reither G, Subramanian D, Mall MA, Plettenburg O, Schultz C. FRET-based and other fluorescent proteinase probes. Biotechnol J 2014; 9:266-81. [PMID: 24464820 DOI: 10.1002/biot.201300201] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2013] [Revised: 10/25/2013] [Accepted: 12/24/2013] [Indexed: 12/28/2022]
Abstract
The continuous detection of enzyme activities and their application in medical diagnostics is one of the challenges in the translational sciences. Proteinases represent one of the largest groups of enzymes in the human genome and many diseases are based on malfunctions of proteolytic activity. Fluorescent sensors may shed light on regular and irregular proteinase activity in vitro and in vivo and provide a deeper insight into the function of these enzymes and their role in pathophysiological processes. The focus of this review is on Förster resonance energy transfer (FRET)-based proteinase sensors and reporters because these probes are most likely to provide quantitative data. The medical relevance of proteinases are discussed using lung diseases as a prominent example. Probe design and probe targeting are described and fluorescent probe development for disease-relevant proteinases, including matrix-metalloproteinases, cathepsins, caspases, and other selected proteinases, is reviewed.
Collapse
Affiliation(s)
- Hai-Yu Hu
- European Molecular Biology Laboratory (EMBL), Cell Biology and Biophysics Unit, Heidelberg, Germany; Sanofi Deutschland GmbH, Diabetes Division, R&D, Industriepark Hoechst, Frankfurt am Main, Germany
| | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose sensing to stimulate insulin secretion therefore elevated glucose concentrations prevail. Persistently elevated glucose concentrations above the physiological range result in the manifestation of hyperglycemia. With systemic insulin resistance, insulin signaling within glucose recipient tissues is defective therefore hyperglycemia perseveres. Beta cell dysfunction supersedes insulin resistance in inducing diabetes. Both pathological states influence each other and presumably synergistically exacerbate diabetes. Preserving beta cell function and insulin signaling in beta cells and insulin signaling in the glucose recipient tissues will maintain glucose homeostasis.
Collapse
Affiliation(s)
- Marlon E. Cerf
- Diabetes Discovery Platform, South African Medical Research CouncilCape Town, South Africa
- *Correspondence: Marlon E. Cerf, Diabetes Discovery Platform, South African Medical Research Council, PO Box 19070, Tygerberg, Cape Town 7505, South Africa. e-mail:
| |
Collapse
|